Gold tier: mechanically validated evidence, with its primary source.
1,713 evidence items · page 65 / 69
10.6 %In 2009, 10.6% of Kenya's population lived in areas where predicted Plasmodium falciparum parasite rate in children aged 2 to <10 years (PfPR2-10) was greater than or equal to 40%.
Kenyapaludismeobserved 2009published 2009BMC infectious diseaseseurope_pmcdocument of 6 observationsDOI 10.1186/1471-2334-9-180
118 casesOver a period of 4 years, 118 of 223 children who received the RTS,S/AS01E vaccine had at least 1 episode of clinical malaria.
Kenyapaludismeobserved 4 yearspublished 2013The New England journal of medicineeurope_pmcdocument of 9 observations
68.2 %Fewer of the blood-fed mosquitoes had fed on man in houses where people slept under bednets (68.2%) than in those without (81.5%).
Kenyapaludismepublished 1989Medical and veterinary entomologyeurope_pmcdocument of 7 observations
37 %37% of visits among ITN users were associated with positive malaria slides.
Kenyapaludismepublished 2017Wellcome open researcheurope_pmcdocument of 7 observations
59 %Of those tested, 59% were malaria-positive.
Kenyapaludismepublished 2026Malaria journalPubMeddocument of 5 observations
5 %Malaria prevalence was 5% in the Coastal Endemic zone in 2020.
Kenyapaludismeobserved 2020published 2026Malaria journalPubMeddocument of 4 observations
74.8 %Mutant Pfmdr1-86Y decreased across years from 74.8% in 1996 to zero in 2017 in Asembo, Kenya.
Kenyapaludismeobserved 1996published 2022Malaria journalPubMeddocument of 10 observations
3.81 USDThe cost of getting an insecticide-treated net and K-O TAB to an antenatal clinic facility ready for distribution to a pregnant woman in Kenya in 2001 was US$ 3.81.
Kenyapaludismeobserved 2001published 2002Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observations
14.9 %Red cell distribution width was increased in malaria-infected children with HbSS genotype, with a median of 14.9% and interquartile range of 3.3, and statistical significance P = 0.030.
Kenyapaludismepublished 2021BMC infectious diseasesPubMeddocument of 13 observations
107 countries_and_territoriesMalaria transmission occurs in 107 countries and territories containing close to 50 percent of the world's population.
Kenyapaludismepublished 2006Conquering Malariaeurope_pmcdocument of 6 observations
57.4 %Plasmodium falciparum was the most prevalent malaria species among 1,134 malaria-positive samples, accounting for 57.4% of infections.
Kenyapaludismepublished 2021The American journal of tropical medicine and hygienePubMeddocument of 7 observations
6.5 monthsRTS,S/AS01 induced high levels of anti-CSP IgG antibodies which exhibited a rapid waning over 6.5 months post-vaccination, followed by a slower decay over the subsequent years.
Kenyapaludismepublished 2021Malaria journalPubMeddocument of 5 observations
All locally acquired malaria infections in the Aseer region were caused by Plasmodium falciparum.
Kenyapaludismepublished 2016Malaria journaleurope_pmcdocument of 9 observations
98 %Peri-urban and rural mosquito populations exhibited moderate resistance intensity to deltamethrin with a mortality rate greater than 98% at 10x concentration.
Kenyapaludismeobserved 2022-2023published 2024PloS onePubMeddocument of 25 observations
57 USDUnit recurrent costs per admission in Kilifi District Hospital ranged from US $57 for 'other' paediatric malaria to US $105 for cerebral malaria.
Kenyapaludismepublished 1998Tropical medicine & international health : TM & IHeurope_pmcdocument of 5 observations
84 %Plasmodium falciparum prevalence was 84–54% between 1992 and 2000 in Magoda village.
Kenyapaludismeobserved 1992-2000published 2018Malaria journaleurope_pmcdocument of 10 observations
Facility-based data showed a decrease in health care utilization for respiratory infections, enteric illnesses, and malaria after the start of COVID-19 measures in Kenya in March 2020.
Kenyaenteric illnesses · paludisme · respiratory infectionsobserved March 2020published 2023Journal of global healthPubMeddocument of 3 observations
2.04 ORCompliance with withholding anti-malarial treatment for test-negative patients increased annually in lake endemic areas of Kenya with an odds ratio of 2.04.
Kenyapaludismepublished 2020Malaria journaleurope_pmcdocument of 9 observationsDOI 10.1186/s12936-020-03479-z
63 percentage_pointsThe provision of RDTs coupled with TGS reduced recommended treatment by 63 percentage points.
Kenyapaludismepublished 2009The American journal of tropical medicine and hygieneeurope_pmcdocument of 6 observationsDOI 10.4269/ajtmh.2009.80.919
71 %Seventy-one percent of HIV-1 infected volunteers were positive for Plasmodium 18S, corresponding to 132 out of 186 individuals.
Kenyapaludisme · VIH/sidapublished 2021The American journal of tropical medicine and hygienePubMeddocument of 7 observations
44 %The HRP2- and PfLDH-based RDTs showed positivity rates of 44% and 45%, respectively.
Kenyapaludismepublished 2026Malaria journalPubMeddocument of 7 observations
0.21 beta_coefficientAdults were associated with higher seroprevalence estimates to Pfs230 in comparison to children (β coefficient 0.21, 95% CI: 0.05–0.38, p = 0.042).
Kenyapaludismepublished 2019Frontiers in immunologyeurope_pmcdocument of 3 observations
880 cases_averted_per_1000_full_dose_equivalentsIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 RTS,S full-dose equivalents at month 32 post-dose 1, was 880 for group Fx017-20-32.
Ghana · Kenyapaludismepublished 2024The Journal of infectious diseasesPubMeddocument of 9 observations
4,288 KShThe mean health system cost per patient admitted with a malaria diagnosis was Kenyan Shilling (KSh) 4288 (USD 42.0).
Kenyapaludismeobserved June 2016 to May 2017published 2021Malaria journalPubMeddocument of 11 observations
0.04 odds_ratioParticipants with submicroscopic parasitemia had a lower risk of gametocytemia compared with microscopic parasitemia (odds ratio 0.04).
Kenyapaludismepublished 2023Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.